ANIX today
$2.78-$0.28 (-9.15%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns down below $1.33
Key levels
Resistance$3.32
Resistance$2.99
Support$2.63
Support$2.35
Latest news & SEC filings
ProductAnixa Biosciences to share ESMO data from cell therapy study in ovarian tumors
NewsAnixa Biosciences CEO Amit Kumar buys 5,000 shares at $3.17 each
SEC FilingAnixa Biosciences Inc filed an insider trading report (Form 4)
ProductAnixa Biosciences finishes dosing fifth group in ovarian cancer CAR-T study
ProductAnixa Biosciences finishes dosing fifth group in Phase 1 ovarian cancer CAR-T trial
All ANIX news →About Anixa Biosciences
Anixa Biosciences develops treatments and preventive shots aimed at cancer. Its lead efforts include a modified T cell therapy for ovarian tumors and vaccines targeting breast and ovarian malignancies, plus early work on shots for lung, colon and prostate cancers. The company runs these programs through its subsidiary Certainty Therapeutics and partners with institutions such as the Cleveland Clinic and Moffitt Cancer Center.
Based on the company's 10-K filed Jan 12, 2026.
Nasdaq · Healthcare
Anixa Biosciences Inc (ANIX)
What Is the Price Target for ANIX?
SEPT Low Target
$6.00
SEPT Mid Target
$6.00
SEPT High Target
$6.00
Analyst Consensus
$6.00
Is ANIX a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.0% YoY with ACCELERATING trend — accelerating momentum.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ANIX.
Start Free Trial →Is ANIX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$4.77
27
Moat Score
NONE
1/9
Piotroski Score
-23.3
Altman Z-Score
What Is Smart Money Doing with ANIX?
Insider Signal
BUYING
7 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| KUMAR AMIT | director officer | Buy | 8,000 | $22K | Oct 22, 2026 |
| Catelani Michael | officer | Buy | 5,500 | $16K | Sep 30, 2026 |
| KUMAR AMIT | director officer | Buy | 7,000 | $19K | Sep 24, 2026 |
| Baskies Arnold M | director | Buy | 5,000 | $14K | Sep 24, 2026 |
| Titterton Lewis H jr | director | Buy | 49,036 | $132K | Sep 23, 2026 |
| KUMAR AMIT | director officer | Buy | 5,000 | $14K | Sep 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ANIX Growth Story
Revenue YoY
0.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
12.82%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for ANIX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ANIX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:54:32 | $2.83 | 2,000 | $$6K | MIDPOINT |
| 20:47:24 | $2.84 | 1,000 | $$3K | BUY |
| 20:34:10 | $2.82 | 1,000 | $$3K | SELL |
| 20:29:24 | $2.80 | 4,499 | $$13K | BUY |
| 20:23:49 | $2.79 | 1,000 | $$3K | SELL |
5 dark pool trades shown · $$27K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Anixa Biosciences Inc (ANIX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ANIX — frequently asked questions
What is ANIX stock price today?
Anixa Biosciences Inc (ANIX) is at $2.78, down 9.15% (-$0.28) at the Nov 11, 2026 close.
Why is ANIX stock moving today?
Latest ANIX news — Nov 4, 2026: Anixa Biosciences to share ESMO data from cell therapy study in ovarian tumors · Nov 2, 2026: Anixa Biosciences CEO Amit Kumar buys 5,000 shares at $3.17 each
What is the ANIX price target?
The average analyst price target for ANIX is $6.00, ranging from $6 to $6, based on 1 analysts. Latest: HC Wainwright & Co. maintains on Sep 22, 2026.
What do analysts rate ANIX?
Analyst ratings for ANIX: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did ANIX beat earnings?
ANIX last reported on Sep 9, 2026: EPS -$0.08 vs -$0.08 expected — a beat of 3.3%.
Does ANIX pay a dividend?
ANIX does not currently pay a dividend.
What are ANIX support and resistance levels?
Support: $2.63, $2.35. Resistance: $2.99, $3.32, $3.65.
What are insiders doing with ANIX?
Insider activity: BUYING, 7 buys and 0 sells in the last 90 days.
What is the latest news on ANIX?
Nov 4, 2026: Anixa Biosciences to share ESMO data from cell therapy study in ovarian tumors · Nov 2, 2026: Anixa Biosciences CEO Amit Kumar buys 5,000 shares at $3.17 each · Nov 2, 2026: Anixa Biosciences Inc filed an insider trading report (Form 4)